Author Details

Tyldesley, S., BC Cancer Agency, Canada

  • Vol 22, No 3 (2015) - Oncologic Pathology
    Using proliferative markers and Oncotype DX in therapeutic decision-making for breast cancer: the B.C. experience
    Abstract  PDF  HTML